NR2F6, a new immune checkpoint that acts as a potential biomarker of immunosuppression and contributes to poor clinical outcome in human glioma
Article in Frontiers in Immunology (July 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (July 2023)
Article in Journal of Oncology (March 2022)
Preprint in Research Square (February 2022)